Intel Emerges as Key Contender in Apple’s Chip Manufacturing Strategy Shift 
AMD Q1 Earnings Surge on AI Demand, Stock Jumps After Strong Guidance 
Shell Q1 Profit Surges to Two-Year High as Dividend Rises Despite War-Driven Debt Pressure 
UOB Q1 Profit Meets Expectations as Loan Growth Offsets Lower Interest Rates 
Aker BP Q1 Profit Jumps on Higher Oil Prices and Asset Reversal 
Arm Stock Drops Despite Strong AI Chip Demand and Earnings Beat 
BHP Attracts AI-Focused Investors as Copper Demand Surges 
Hugo Boss Beats Q1 Profit Expectations Despite Market Headwinds 
Philips Reaffirms 2026 Outlook After Strong Q1 Sales and Margin Beat 
Palantir Reports Record Growth, Raises 2026 Revenue Outlook Above Expectations 
Strategy Reports Q1 Loss as Bitcoin Holdings Trigger $14.46 Billion Unrealized Hit 
Supermicro Forecasts Strong Q4 Revenue Growth as AI Server Demand Surges 
Rivian Hints at New R2 Variants as Production Ramps Up Ahead of 2027 Launch 
Infineon Raises 2026 Outlook as AI Data Center Chip Demand Surges 
BMW Keeps 2026 Outlook Despite 25% Profit Drop Amid Tariff Pressure 
Volvo Car Sales Drop 10% in Early 2026 Despite Growth in Electric Vehicles 
Hua Hong Semiconductor Stock Surges to Multi-Year High Amid AI Boom 
DALLAS, May 01, 2018 -- Via OTC PR Wire – Puration, Inc. (USOTC:PURA) Today announced plans to produce a THC infused beverage in Canada in conjunction with a previously announced pending acquisition intended to establish a cannabis cultivation operation for the recreational marijuana market expected to be legalized nationwide in Canada this summer. The new THC infused beverage will expand Puration’s current cannabis infused beverage business. Last year, Puration introduced EVERx, a CBD infused sports water. The sales of EVERx yielded over a 60% gross margin as reported in the company’s 2017 annual report. The initial sales have won the interest of additional distributors to include a recently announced national distribution contract. Puration has designed a THC infused beverage and registered the name THCSavor. Package design is underway. Highlights of the THCSavor go-to-market plan are to be included in the upcoming shareholder presentation scheduled for, Thursday next week, on May 10th, to provide overall details on the Canadian business acquisition expected to be closed as early as the end of this week.
For more information on Puration, visit http://www.aciconglomerated.com.
Disclaimer/Safe Harbor:
This news release contains forward-looking statements within the meaning of the Securities Litigation Reform Act. The statements reflect the Company's current views with respect to future events that involve risks and uncertainties. Among others, these risks include the expectation that any of the companies mentioned herein will achieve significant sales, the failure to meet schedule or performance requirements of the companies' contracts, the companies' liquidity position, the companies' ability to obtain new contracts, the emergence of competitors with greater financial resources and the impact of competitive pricing. In the light of these uncertainties, the forward-looking events referred to in this release might not occur. These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.
Puration, Inc.
Brian Shibley,
[email protected]
+1-800-861-1350
